Plunkett Research Online: Vaccinex Inc

VACCINEX INC (VCNX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Vaccinex Inc is pioneering a differentiated approach to treating cancer and slowly progressive neurodegenerative diseases through the inhibition of semaphorin 4D (SEMA4D). The company’s lead drug candidate, pepinemab, blocks SEMA4D, a potent biological effector that it believes prevents immune infil.....


VACCINEX INC

Ticker: VCNX
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 585 271-2700
Fax:
Address:
Rochester, NY 14620 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Maurice ZaudererCEO/Director/Founder/President
Jill SanchezCFO/Chief Accounting Officer
See More
Vaccinex Inc is pioneering a differentiated approach to treating cancer and slowly progressive neurodegenerative diseases through the inhibition of semaphorin 4D (SEMA4D). The company’s lead drug candidate, pepinemab, blocks SEMA4D, a potent biological effector that it believes prevents immune infil.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture